{
  "report_rows": [
    {
      "kpi": "Comp SSS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~1.2% vs cons 0.03%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "EPS-Diluted (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$0.84 vs cons $0.823",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net Sales (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.63B vs cons $4.592B",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 EPS (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~$2.18 mid vs cons $2.046",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Comp SSS (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide floor ~1% vs cons 0.45%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "H2 Gross Margin Direction",
      "prediction": "UNCHANGED",
      "answer": "Reaffirm H2 expansion; DC on track",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.0,
  "day5_path": "FADE",
  "day5_rationale": "FADE \u2014 estimates partially revise up but not to guidance midpoint; pet structural overhang and Street credibility gap persist",
  "day5_confidence": "MEDIUM"
}